186 related articles for article (PubMed ID: 31772299)
1. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL.
Rodriguez S; Abundis C; Boccalatte F; Mehrotra P; Chiang MY; Yui MA; Wang L; Zhang H; Zollman A; Bonfim-Silva R; Kloetgen A; Palmer J; Sandusky G; Wunderlich M; Kaplan MH; Mulloy JC; Marcucci G; Aifantis I; Cardoso AA; Carlesso N
Leukemia; 2020 May; 34(5):1241-1252. PubMed ID: 31772299
[TBL] [Abstract][Full Text] [Related]
2. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells.
Kullmann MK; Grubbauer C; Goetsch K; Jäkel H; Podmirseg SR; Trockenbacher A; Ploner C; Cato AC; Weiss C; Kofler R; Hengst L
Cell Cycle; 2013 Aug; 12(16):2625-35. PubMed ID: 23907123
[TBL] [Abstract][Full Text] [Related]
3. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
4. Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0/G1 arrest mediated by inhibition of Skp2 transcription.
Center DM; Cruikshank WW; Zhang Y
J Immunol; 2004 Feb; 172(3):1654-60. PubMed ID: 14734747
[TBL] [Abstract][Full Text] [Related]
5. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
[TBL] [Abstract][Full Text] [Related]
7. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
8. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation.
Sarmento LM; Huang H; Limon A; Gordon W; Fernandes J; Tavares MJ; Miele L; Cardoso AA; Classon M; Carlesso N
J Exp Med; 2005 Jul; 202(1):157-68. PubMed ID: 15998794
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
11. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
[TBL] [Abstract][Full Text] [Related]
15. Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
Wang G; Chan CH; Gao Y; Lin HK
Chin J Cancer; 2012 Apr; 31(4):169-77. PubMed ID: 22200179
[TBL] [Abstract][Full Text] [Related]
16. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
[TBL] [Abstract][Full Text] [Related]
17. The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs.
Rodriguez S; Wang L; Mumaw C; Srour EF; Lo Celso C; Nakayama K; Carlesso N
Blood; 2011 Jun; 117(24):6509-19. PubMed ID: 21502543
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms in cardiac fibroblast growth: an obligate role for Skp2 and FOXO3a in ERK1/2 MAPK-dependent regulation of p27kip1.
Pramod S; Shivakumar K
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H844-55. PubMed ID: 24441545
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells.
Wang D; Qin H; Du W; Shen YW; Lee WH; Riggs AD; Liu CP
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9493-8. PubMed ID: 22645357
[TBL] [Abstract][Full Text] [Related]
20. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]